Ginkgo Biloba Extract in the Treatment of Schizophrenia

• Status: Completed
• Trial end date: 2018-08-15
• Target enrollment: 0
• Participant gender: All

Summary

We investigated the effects of Ginkgo biloba extract on the symptoms and cognitive functioning in patients with schizophrenia

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Beijing HuiLongGuan Hospital

Criteria

Inclusion Criteria:

• Diagnosis of schizophrenia by two senior psychiatrists

• Between 18 and 60 years and Han Chinese

• Duration of symptoms at least 12 months

• Current psychotic symptoms of moderate severity

Exclusion Criteria:

• A Diagnostic and Statistical Manual of Mental Disorders IV Axis I diagnosis other than schizophrenia

• Documented disease of physical diseases including, but not limited to stroke, tumor, Parkinson's disease, Huntington's disease, seizure, epilepsy, history of brain trauma；

• Pregnant or breast-feeding female'

• Subjects who suffered from alcohol or illegal durg abuse/dependence